发明名称 |
INHIBITORS OF MICRORNAs THAT REGULATE PRODUCTION OF ATRIAL NATRIURETIC PEPTIDE (ANP) AS THERAPEUTICS AND USES THEREOF |
摘要 |
The present invention relates to methods, kits and compositions to treat hypertension and other cardiovascular diseases in a subject, in particular, a method of treating or preventing a cardiovascular disease in a subject comprising administering to a subject at least one anti-miR agent to miRNA-425. In some embodiments, an anti-miR agent is a small molecule or an oligonucleotide complementary to at least part of the miR-425 of SEQ ID NO: 1, or an anti-miR complementary to at least part of the miRNA seed sequence AUGACA (SEQ ID NO: 2). Another aspect of the present invention relates to methods, kits and compositions to treat low blood pressure in a subject comprising administering a composition comprising a miR-425 agent to decrease ANP levels in the subject. Other aspects of the present invention relates to assays, methods and systems to identify a subject at risk of hypertension, or identifying a subject suitable to administration of an anti-miR-425 agent for treatment of hypertension, the assay comprising assessing if a subject is homozygous or heterozygous for the major (A) allele of rs5068 SNP, and/or assaying for levels of miR-425 and/or assaying for levels of NT-proANP and/or levels of ANP in the plasma of a subject. |
申请公布号 |
US2015133521(A1) |
申请公布日期 |
2015.05.14 |
申请号 |
US201314408189 |
申请日期 |
2013.06.14 |
申请人 |
THE GENERAL HOSPITAL CORPORATION |
发明人 |
Bloch Kenneth D.;Arora Pankaj;Newton-Cheh Christopher;Wang Thomas J. |
分类号 |
C12N15/113;A61K45/06;C12Q1/68;A61K31/7088 |
主分类号 |
C12N15/113 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of inhibiting or preventing hypertension or a symptom thereof in a subject in need thereof, the method comprising administering to a subject determined to homozygous (AA) or heterozygous (AG) for A allele for the single nucleotide polymorphism (SNP) rs5068 (A/G) an effective amount of an inhibitor of miRNA-425 activity. |
地址 |
Bouston MA US |